Influenza vaccination in patients with end-stage renal disease: Systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Remschmidt, Cornelius ^a   Wichmann, Ole ^a   Harder, Thomas ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Dialysis; Effectiveness; End stage renal disease; GRADE; Influenza; Systematic review; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; BACTEREMIA; CAUSE OF DEATH; CLINICAL EVALUATION; COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; EMBASE; END STAGE RENAL DISEASE; EVIDENCE BASED PRACTICE; FLU LIKE SYNDROME; HEART DEATH; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MEDLINE; META ANALYSIS; METHODOLOGY; OBSERVATIONAL STUDY; PNEUMONIA; QUALITY CONTROL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT INFECTION; SEASONAL INFLUENZA; SEPTICEMIA; STATISTICAL BIAS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIREMIA; ADVERSE EFFECTS; CHRONIC KIDNEY FAILURE; INFLUENZA, HUMAN; VACCINATION;

HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; VACCINATION;

EID: 84924083686     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0244-9     Document Type: Article

References (42)

1. Anand S, Bitton A, Gaziano T: The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One 2013, 8:e72860.
2. U.S. Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013.
3. White SL, Chadban SJ, Jan S, Chapman JR, Cass A: How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 2008, 86:229-237.
4. Descamps-Latscha B: The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993, 2:883-891.
5. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R: Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int 2008, 28:S183-S187.
6. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008, 3:1526-1533.
7. Naqvi SB, Collins AJ: Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006, 13:199-204.
8. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000, 58:1758-1764.
9. Sarnak MJ, Jaber BL: Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001, 120:1883-1887.
10. Centers for Disease Control and Prevention (CDC): Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. MMWR Recomm Rep 2013, 62:1-43.
11. Public Health England: Chapter 19: Influenza. In The Green Book; 2013. Updated 11 September 2013. [https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19 ]. Accessed on 20 March 2014
12. National Advisory Committee on Immunization (NACI): Statement on Seasonal Influenza Vaccine for 2013-2014. In Canada Communicable Disease Report. October 2013, Volume 39, ACS-4; 2013. [http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/13vol39/acs-dcc-4/index-eng.php ]. Accessed on 19 March, 2014.
13. German Standing Committee on Vaccination (STIKO): Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: August 2013. In Epidemiologisches Bulletin 34/2013; 2013. [http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2013/Ausgaben/34_13.pdf?__blob=publicationFile ]. Accessed on 19 March 2014
14. Mastalerz-Migas A, Steciwko A, Brydak LB: Immune response to influenza vaccine in hemodialysis patients with chronic renal failure. Adv Exp Med Biol 2013, 756:285-290.
15. Vogtlander NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD: Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 2004, 22:2199-2201.
16. Scharpe J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P: Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009, 54:77-85.
17. Remschmidt C, Wichmann O, Harder T: Methodological quality of systematic reviews on influenza vaccination. Vaccine 2014, 32:1678-1684.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W264.
19. CASP UK: Critical Appraisal Skills Programme (CASP) 2014. Oxford: CASP Checklists; 2014 [http://casp-uk.net ]
20. Higgins J, Green S: Cochrane Handbook of Systematic Reviews of Interventions. Cochrane Collaboration; 2011
21. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A: GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011, 64:380-382.
22. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
23. Wang IK, Lin CL, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Morisky DE, Huang CC, Sung FC: Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One 2013, 8:e58317.
24. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ: Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 2003, 63:738-743.
25. Bond TC, Spaulding AC, Krisher J, McClellan W: Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis 2012, 60:959-965.
26. McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, Sturmer T, Brookhart MA: Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med 2012, 172:548-554.
27. Slinin Y, Foley RN, Collins AJ: Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int 2006, 70:1135-1141.
28. Centers for Disease C, Prevention: Update: influenza activity--United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine. MMWR Morb Mortal Wkly Rep 1998, 47:280-284.
29. Centers for Disease C, Prevention: Update: influenza activity--United States, 1997-98 season. MMWR Morb Mortal Wkly Rep 1998, 47:196-200.
30. European Medicines Agency: Explanatory Note on the Withdrawal of the Note for Guidance on Harmonisation of Requirements for Influenza Vaccines and of the Core SmPC/PL for Inactivated Seasonal Influenza Vaccines; 2014. [http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/07/WC500170300.pdf ]. Accessed on 6 June, 2014.
31. Reber A, Katz J: Immunological assessment of influenza vaccines and immune correlates of protection. Expert Rev Vaccines 2013, 12:519-536.
32. Beyer WE: Heterogeneity of case definitions used in vaccine effectiveness studies-and its impact on meta-analysis. Vaccine 2006, 24:6602-6604.
33. Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA: Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax 2013, 68:658-663.
34. Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, Narwaney K, Jacobsen SJ, Shay DK, Jackson LA: Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol 2013, 178:1327-1336.
35. Wong K, Campitelli MA, Stukel TA, Kwong JC: Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med 2012, 172:484-491.
36. Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C: Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014, 3:CD001269.
37. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE: Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 2:CD004876.
38. Evison J, Farese S, Seitz M, Uehlinger DE, Furrer H, Muhlemann K: Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 2009, 48:1402-1412.
39. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczynska B, Sieniawska M: Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000, 18:3280-3286.
40. Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F, Perego A, Zanetti AR: Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol 2007, 79:1176-1179.
41. Nikoskelainen J, Vaananen P, Forsstrom J, Kasanen A: Influenza vaccination in patients with chronic renal failure. Scand J Infect Dis 1982, 14:245-251.
42. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T: The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003, 37:71-76.